Literature DB >> 8769132

A carboxy terminal domain of the hMSH-2 gene product is sufficient for binding specific mismatched oligonucleotides.

A Whitehouse1, G R Taylor, J Deeble, S E Phillips, D M Meredith, A F Markham.   

Abstract

The human MSH-2 gene product is a member of a highly conserved family of proteins which are involved in post-replication mismatch repair. hMSH-2 is homologous to Escherichia coli (E. coli) MutS and Sacchromyces cerevisiae MSH-1 and MSH-2 proteins, which recognise heteroduplex DNA at the sites of all single base mismatches and deletions or insertions up to 4 base pairs. hMSH-2 is one of the hereditary non-polyposis colorectal cancer (HNPCC) tumor suppressor genes, and maps to human chromosome 2p16. Alterations in the coding region of the hMSH-2 gene result in a mutator phenotype with marked instability of microsatellite sequences, indicative of a deficiency in DNA repair. It has been shown that purified hMSH-2 binds specifically to nucleotide mismatches in double-stranded DNA. Here we demonstrate that a region of high homology between the members of this class of proteins contains a type A nucleotide binding site consensus sequence which has ATPase activity and is sufficient to bind DNA containing specific mismatched residues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8769132     DOI: 10.1006/bbrc.1996.1168

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

2.  A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.

Authors:  Z Q Yuan; N Wong; W D Foulkes; L Alpert; F Manganaro; C Andreutti-Zaugg; R Iggo; K Anthony; E Hsieh; M Redston; L Pinsky; M Trifiro; P H Gordon; D Lasko
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

3.  Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer.

Authors:  K M Lin; M Shashidharan; A G Thorson; C A Ternent; G J Blatchford; M A Christensen; P Watson; S J Lemon; B Franklin; B Karr; J Lynch; H T Lynch
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.